文献速递心血管胸部CT

食管癌患者冠脉CTA评估及心血管不良事件预测

Evaluating Coronary Arteries and Predicting Major Adverse Cardiovascular Events in Patients with Esophageal Cancer Using Coronary CT Angiography.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

前瞻性纳入140例接受化疗或放化疗的食管鳞癌患者,采用冠脉CTA评估治疗前后冠状动脉变化。结果显示治疗后CT-FFR下降、FAI升高,且放化疗组变化更显著。基线FAI是主要心血管不良事件的独立预测因子。

要点

  • 食管癌化疗或放化疗后冠脉CT-FFR下降、FAI升高,提示治疗相关冠脉改变
  • 基线LAD、LCX、RCA的FAI可独立预测MACE发生
  • 放化疗较单纯化疗引起更显著的CT-FFR降低和FAI升高

核心结论

  • 食管鳞癌患者接受化疗或放化疗后CT-FFR下降、FAI升高,基线FAI是MACE的独立预测因子

研究设计与样本

  • 前瞻性研究,2020年7月至2022年8月纳入140例拟行化疗或放化疗的食管鳞癌患者
  • 患者平均年龄65岁±8.39,男性76例(54%),60例接受化疗,80例接受放化疗
  • 采用冠脉CT血管成像(CCTA)参数评估冠状动脉改变,以MACE为结局指标
  • MACE定义为心肌梗死、卒中、完全性心脏传导阻滞、心血管死亡或因心力衰竭或加重性心绞痛再住院

关键影像表现/征象

  • 化疗或放化疗后CT-FFR下降,FAI升高
  • 放化疗后CT-FFR低于化疗后:LAD为0.75对0.82,LCX为0.74对0.77,RCA为0.74对0.77(P<.001)
  • 放化疗后FAI高于化疗后:LAD为-70.0对-75.0 HU,LCX为-75.0对-77.5 HU,RCA为-76.0对-78.5 HU(P<.001)

诊断标准与关键数值

  • 基线LAD、LCX、RCA的FAI与MACE发生独立相关,HR分别为3.99、3.85、3.41(P<.001)
  • 放化疗后CT-FFR:LAD为0.75,LCX为0.74,RCA为0.74;化疗后CT-FFR:LAD为0.82,LCX为0.77,RCA为0.77
  • 放化疗后FAI:LAD为-70.0 HU,LCX为-75.0 HU,RCA为-76.0 HU;化疗后FAI:LAD为-75.0 HU,LCX为-77.5 HU,RCA为-78.5 HU

临床应用与阅片要点

  • 食管癌患者治疗前CCTA基线FAI可作为心血管风险分层参考
  • 治疗后CCTA随访有助于识别冠脉功能性改变,尤其是接受放化疗者

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate alterations in coronary arteries in individuals with esophageal squamous cell carcinoma (ESCC) who received chemotherapy or chemoradiotherapy using coronary CT angiography (CCTA) parameters and explore their association with major adverse cardiovascular events (MACEs). Materials and Methods Between July 2020 and August 2022, individuals with ESCC scheduled for chemotherapy or chemoradiotherapy who underwent CCTA were prospectively included. MACEs were defined as myocardial infarction, stroke, complete heart block, cardiovascular death, or rehospitalization due to heart failure or aggravated angina symptoms. The outcome time frame was measured from treatment initiation until the occurrence of MACEs or the end of follow-up, whichever occurred first. Associations between CCTA parameters and MACEs were analyzed by Cox regression analyses. Results Among the 140 enrolled participants (mean age ± SD, 65 years ± 8.39; 76 [54%] male), 60 received chemotherapy, and 80 received chemoradiotherapy. The CT fractional flow reserve (FFR) decreased and the fat attenuation index (FAI) increased after chemotherapy or chemoradiotherapy. Moreover, a lower CT FFR (left anterior descending artery [LAD], 0.75 vs 0.82; left circumflex artery [LCX], 0.74 vs 0.77; right coronary artery [RCA], 0.74 vs 0.77; P < .001) and higher FAI (LAD, -70.0 vs -75.0 HU; LCX, -75.0 vs -77.5 HU; RCA, -76.0 vs -78.5 HU; P < .001) were observed after chemoradiotherapy than after chemotherapy. The baseline FAIs of the LAD, LCX, and RCA were independently associated with the occurrence of MACE (hazard ratio = 3.99, 3.85, and 3.41, respectively; P < .001). Conclusion CT FFR decreased and the FAI increased after chemotherapy or chemoradiotherapy in individuals with ESCC. The baseline FAI was a predictor of MACEs. Keywords: CT-Coronary Angiography, Radiation Therapy/Oncology, Cardiac, Coronary Arteries, Esophagus, Esophageal Neoplasms, Chemoradiotherapy, Fractional Flow Reserve, Major Adverse Cardiac Events Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Yang, Xu, Tu, et al. Evaluating Coronary Arteries and Predicting Major Adverse Cardiovascular Events in Patients with Esophageal Cancer Using Coronary CT Angiography. Radiol Cardiothorac Imaging. 2026. PMID: 42274325. doi:10.1148/ryct.240534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。